AAAAAA

   
Results: 1-11 |
Results: 11

Authors: BOOIJ J ANDRINGA G RIJKS LJM VERMEULEN RJ DEBRUIN K BOER GJ JANSSEN AGM VANROYEN EA
Citation: J. Booij et al., [I-123] FP-CIT BINDS TO THE DOPAMINE TRANSPORTER AS ASSESSED BY BIODISTRIBUTION STUDIES IN RATS AND SPECT STUDIES IN MPTP-LESIONED MONKEYS, Synapse, 27(3), 1997, pp. 183-190

Authors: STOOF JC VERMEULEN RJ VANROYEN EA DRUKARCH B VOORN P WOLTERS EC GROENEWEGEN HJ
Citation: Jc. Stoof et al., DOPAMINERGIC SYSTEMS AND PARKINSONS-DISEASE - SOME LATEST DEVELOPMENTS IN PATHOGENETIC, DIAGNOSTIC AND PHARMACOTHERAPEUTIC INVESTIGATIONS, Neuroscience research communications, 18(3), 1996, pp. 133-142

Authors: RIJKS LJ BOOIJ J DOORNBOS T BOER GJ RONKEN E DEBRUIN K VERMEULEN RJ JANSSEN AGM VANROYEN EA
Citation: Lj. Rijks et al., IN-VITRO AND IN-VIVO CHARACTERIZATION OF NEWLY DEVELOPED IODINATED 1-(2-[BIS(4-FLUOROPHENYL)METHOXY]ETHYL) PIPERAZINE DERIVATIVES IN RATS -LIMITED VALUE AS DOPAMINE TRANSPORTER SPECT LIGANDS, Synapse, 23(3), 1996, pp. 201-207

Authors: VERMEULEN RJ DRUKARCH B SAHADAT MCR GOOSEN C SCHOFFELMEER ANM WOLTERS EC STOOF JC
Citation: Rj. Vermeulen et al., MORPHINE AND NALTREXONE MODULATE D-2 BUT NOT D-1 RECEPTOR-INDUCED MOTOR BEHAVIOR IN MPTP-LESIONED MONKEYS, Psychopharmacology, 118(4), 1995, pp. 451-459

Authors: VERMEULEN RJ WOLTERS RC TISSINGH G BOOIJ J JANSSEN AGM HABRAKEN J SOKOLEBUSEMANN E STOOF JC VANROYEN EA
Citation: Rj. Vermeulen et al., EVALUATION OF [I-123] BETA-CIT BINDING WITH SPECT IN CONTROLS, EARLY AND LATE PARKINSONS-DISEASE, Nuclear medicine and biology, 22(8), 1995, pp. 985-991

Authors: DUBOIS EA VERMEULEN RJ JANSSEN AFM
Citation: Ea. Dubois et al., IMAGING AND QUANTIFICATION OF MUSCARINIC RECEPTORS IN THE HUMAN HEARTAND BRAIN IN-VIVO, British Journal of Pharmacology, 114, 1995, pp. 142-142

Authors: VERMEULEN RJ JONGENELEN CAM LANGEVELD CH WOLTERS EC STOOF JC DRUKARCH B
Citation: Rj. Vermeulen et al., DOPAMINE D-1 RECEPTOR AGONISTS DISPLAY A DIFFERENT INTRINSIC ACTIVITYIN RAT, MONKEY AND HUMAN ASTROCYTES, European journal of pharmacology. Molecular pharmacology section, 269(1), 1994, pp. 121-125

Authors: VERMEULEN RJ DRUKARCH B VERHOEFF NPLG GOOSEN C SAHADAT MCR WOLTERS EC VANROYEN EA STOOF JC
Citation: Rj. Vermeulen et al., NO DIRECT CORRELATION BETWEEN BEHAVIORALLY ACTIVE DOSES OF THE DOPAMINE D-2 AGONIST LY-171555 AND DISPLACEMENT OF [I-123] IBZM AS MEASURED WITH SPECT IN MPTP MONKEYS, Synapse, 17(2), 1994, pp. 115-124

Authors: VERMEULEN RJ DRUKARCH B SAHADAT MCR GOOSEN C WOLTERS EC STOOF JC
Citation: Rj. Vermeulen et al., THE DOPAMINE-D-1 AGONIST SKF-81297 AND THE DOPAMINE-D-2 AGONIST LY-171555 ACT SYNERGISTICALLY TO STIMULATE MOTOR BEHAVIOR OF ETHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-LESIONED PARKINSONIAN RHESUS-MONKEYS, Movement disorders, 9(6), 1994, pp. 664-672

Authors: VERMEULEN RJ DRUKARCH B SAHADAT MCR GOOSEN C WOLTERS EC STOOF JC
Citation: Rj. Vermeulen et al., THE DOPAMINE-D-1 AGONIST SKF-81297 AND THE DOPAMINE-D-2 AGONIST LY-171555 ACT SYNERGISTICALLY TO STIMULATE MOTOR BEHAVIOR OF ETHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-LESIONED PARKINSONIAN RHESUS-MONKEYS, Movement disorders, 9(6), 1994, pp. 664-672

Authors: VERMEULEN RJ DRUKARCH B SAHADAT MCR GOOSEN C WOLTERS EC STOOF JC
Citation: Rj. Vermeulen et al., THE SELECTIVE DOPAMINE-D(1) RECEPTOR AGONIST, SKF-81297, STIMULATES MOTOR BEHAVIOR OF MPTP-LESIONED MONKEYS, European journal of pharmacology, 235(1), 1993, pp. 143-147
Risultati: 1-11 |